258 results on '"Magistrelli, Luca"'
Search Results
2. Does thyroid diseases contribute to the natural history of idiopathic adult-onset dystonia? Data from the Italian Dystonia Registry
3. Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life
4. A case of early-onset Parkinson’s disease in a patient with KBG syndrome
5. Relationship between [123I]FP-CIT SPECT data and peripheral CD4 + T cell profile in newly-diagnosed drug-naïve Parkinson’s disease patients
6. The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
7. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
8. The prevention of falls in patients with Parkinson’s disease with in-home monitoring using a wearable system: a pilot study protocol
9. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease
10. The Italian tremor Network (TITAN): rationale, design and preliminary findings
11. Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
12. A very early onset of juvenile parkinsonism
13. The Impact of Probiotics on Clinical Symptoms and Peripheral Cytokines Levels in Parkinson's Disease: Preliminary In Vivo Data.
14. Family History in Parkinson's Disease: A National Cross‐Sectional Study.
15. Primary brain calcification: an international study reporting novel variants and associated phenotypes.
16. Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site
17. Correction to: The Italian tremor Network (TITAN): rationale, design and preliminary findings
18. Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson’s disease
19. Cortical visuomotor interactions in Freezing of Gait: A TMS approach
20. Does sex influence the natural history of idiopathic adult-onset dystonia?
21. Parkinson's disease and chronic inflammatory demyelinating polyneuropathy: Broadening the clinical spectrum of VCP mutations
22. Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series
23. Myoclonus‐Dystonia plus Syndrome in a Patient Carrying a Novel TCF20 Variant.
24. Demographic and clinical determinants of neck pain in idiopathic cervical dystonia
25. Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies
26. Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
27. Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study.
28. Menstrual‐related fluctuations in a juvenile‐onset Parkinson's disease patient treated with STN‐DBS: correlation with local field potentials
29. Validation of the Italian version of the PSP Quality of Life questionnaire
30. Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy
31. Gait Monitoring and Analysis: A Mathematical Approach
32. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
33. Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia
34. Menstrual‐Related Fluctuations in a Juvenile‐Onset Parkinson's Disease Patient Treated with STN‐DBS: Correlation with Local Field Potentials.
35. MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism
36. Phenotypic Variability in Acquired and Idiopathic Dystonia
37. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
38. Phenotypic Variability in Acquired and Idiopathic Dystonia
39. Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study
40. The Immune System as a Therapeutic Target for Old and New Drugs in Parkinson’s Disease
41. Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease
42. Chapter 6 - Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease
43. Clinical correlates of "pure" essential tremor: the TITAN study.
44. Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
45. T Lymphocytes in Parkinson’s Disease
46. Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
47. A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort
48. Relationship between [123I]FP-CIT SPECT data and peripheral CD4 + T cell profile in newly-diagnosed drug-naïve Parkinson's disease patients.
49. The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
50. Effects of Probiotics on peripheral immunity in Parkinson’s Disease: a pilot, randomized, placebo-controlled study to evaluate the efficacy of Probiotics in modulating peripheral immunity in subjects with Parkinson’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.